Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a Limited Competition Notice of Funding Opportunity (NOFO) for the Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network – Clinical Sites. This initiative invites organizations previously funded under RFA-HG-19-013 and RFA-HG-19-014 to participate in a clinical trial aimed at assessing the long-term adherence to and outcomes of genomically informed risk assessments (GIRA) for approximately 25,000 patients. The program is crucial for understanding the effectiveness of GIRA-based preventative recommendations and identifying factors influencing patient adherence. Interested applicants must submit their proposals by January 30, 2026, with an estimated total program funding of $5.8 million allocated for ten awards over the fiscal years 2026 to 2029. For further inquiries, applicants can contact the Division of Genomic Medicine at NHGRI_DGMed@nih.gov.
Eligible Applicants
This is a limited competition NOFO. Only organizations funded under RFA-HG-19-013 and RFA-HG-19-014 are eligible to apply.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.